Study reveals optimal interval for stomach cancer screening

July 16, 2012

A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality.

Although the incidence of has decreased substantially in the western part of the world, the disease is still common in areas such as Eastern Asia, including Korea, Japan, and China.

Gastric cancer patients' strongly depends on the stage of the disease, or how advanced it is, at the time of . In other words, early detection and treatment can save lives.

Gastric is often done by upper endoscopy—using a tiny camera at the end of a long, flexible tube to look at the upper digestive system. To see how often this screening technique should be done to detect gastric cancer at an early stage, Il Ju Choi, MD, PhD, of the National Cancer Center in Korea, and his colleagues studied 2,485 patients who had been diagnosed with gastric cancer at their institution. The researchers divided the patients into the following seven groups based on the interval between the endoscopy that detected gastric cancer and the endoscopy that preceded it: one year, two years, three years, four years, five years, more than five years, and never-screened. Currently, screening every two years is recommended in Korea for individuals who are aged 40 years or older.

The investigators found that gastric cancer stages were similar for screening intervals between one and three years; however, the cancer stage at diagnosis was significantly higher at screening intervals of four years or more.

"The optimal screening strategy appears to be every three years. Gastric cancers are likely to become more advanced before detection with screening intervals that are longer than three years, but screening more frequently than every three years does not appear to be more beneficial," said Dr. Choi. "The exception is if you have a family member with gastric cancer. In that case, you may need to undergo upper endoscopy screening more frequently than every three years," he added. Patients with a family history of gastric cancer were more likely to have a higher stage at diagnosis if they had a three-year interval rather than a one-year interval.

Explore further: Increase in risk of certain gastric cancer from heavy drinking

More information: “Association of the Interval Between Endoscopies with Gastric Cancer Stage at Diagnosis in a Region of High Prevalence.” Ji Hyung Nam, Il Ju Choi, Soo-Jeong Cho, Chan Gyoo Kim, Jae Kwan Jun, Kui Son Choi, Byung-Ho Nam, Jun Ho Lee, Keun Won Ryu, Young-Woo Kim. CANCER. Published Online: July 16, 2012 (DOI: 10.1002/cncr.27495).

Related Stories

Increase in risk of certain gastric cancer from heavy drinking

May 18, 2011
The results from a very well-done meta-analysis support other data generated on the risk of alcohol consumption and gastric cancer – that is – that the risk may be real for heavy alcohol consumption but not for ...

Recommended for you

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

How a non-coding RNA encourages cancer growth and metastasis

August 21, 2017
A mechanism that pushes a certain gene to produce a non-coding form of RNA instead of its protein-coding alternative can promote the growth of cancer, report researchers at the Medical University of South Carolina (MUSC) ...

Spaser can detect, kill circulating tumor cells to prevent cancer metastases, study finds

August 21, 2017
A nanolaser known as the spaser can serve as a super-bright, water-soluble, biocompatible probe capable of finding metastasized cancer cells in the blood stream and then killing these cells, according to a new research study.

Comprehensive genomic analysis offers insights into causes of Wilms tumor development

August 21, 2017
A comprehensive genomic analysis of Wilms tumor - the most common kidney cancer in children - found genetic mutations involving a large number of genes that fall into two major categories. These categories involve cellular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.